[1] Yang JD, Roberts LR. Epidemiology and management of hepatocellular carcinoma[J] . Infectious Disease Clinics of North America, 2010, 24(4):899-919. [2] Liu J, Zhang C, Feng Z. Tumor suppressor p53 and its gain-of-function mutants in cancer[J] . Acta Biochimica et Biophysica Sinica, 2014, 46(3):170-179. [3] Yang Y, Liu W, Ding R, et al. Comprehensive expression profiling and functional network analysis of p53-regulated MicroRNAs in HepG2 Cells treated with doxorubicin[J] . PLoS One, 2016, 11(2):e0149227. [4] Agarwal V, Bell GW, Nam JW, Bartell DP. Predicting effective microRNA target sites in mammalian mRNAs[J] . Elife, 2015, 4:e05005. [5] Chatr-Aryamontri A, Breitkreutz BJ, Oughtred R, et al. The BioGRID interaction database:2015 update[J] . Nucleic Acids Res, 2015, 43(Database issue):D470-478. [6] Betel D, Koppal A, Agius P, et al. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites[J] . Genome Biology, 2010, 11(8):R90. [7] Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools:paths toward the comprehensive functional analysis of large gene lists[J] . Nucleic Acids Research, 2009, 37(1):1-13. [8] Vlachos IS, Paraskevopoulou MD, Karagkouni D, et al. DIANA-TarBase v7. 0:indexing more than half a million experimentally supported miRNA:mRNA interactions[J] . Nucleic Acids Research, 2015, 43(D1):D153-D159. [9] Zeron-Medina J, Wang X, Repapi E, et al. A polymorphic p53 response element in KIT ligand influences cancer risk and hsa undergone natural selection[J] . Cell, 2013, 155(2):410-422. [10] Shannon P, Markiel A, Ozier O, et al. Cytoscape:a software environment for integrated models of biomolecular interaction networks[J] . Genome Research, 2003, 13(11):2498-2504. [11] Park SJ, Yang SW, Kim BC. Transforming growth factor-beta1 induces cell cycle arrest by activating atypical cyclin-dependent kinase 5 through up-regulation of Smad3-dependent p35 expression in human MCF10A mammary epithelial cells[J] . Biochem Biophys Res Commun, 2016, 472(3):502-507. [12] Pal SK, Nguyen CT, Morita KI, et al. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma[J] . J Oral Pathol Med, 2016, 45(10):730-739. [13] Kim W, Kim E, Lee S, et al. TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial-mesenchymal transition[J] . Exp Mol Med, 2016, 48(11):e273. [14] D’Annibale S, Kim J, Magliozzi R, et al. Proteasome-dependent degradation of transcription factor activating enhancer-binding protein 4(TFAP4)controls mitotic division[J] . J Biol Chem, 2014, 289(11):7730-7737. [15] Palaniappan A, Ramar K, Ramalingam S. Computational identification of novel stage-specific biomarkers in colorectal cancer progression[J] . PLoS One, 2016, 11(5):e0156665. [16] Pe?ina-?laus N, Kafka A, Vladu?i? T, et al. AXIN1 expression and localization in meningiomas and association to changes of APC and e-cadherin[J] . Anticancer Res, 2016, 36(9):4583-4594. [17] Sethuraman A, Brown M, Seagroves TN, et al. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway[J] . Breast Cancer Res, 2016, 18(1):81. [18] Yasumoto M, Sakamoto E, Ogasawara S, et al. Muscle RAS oncogene homolog(MRAS)recurrent mutation in Borrmann type IV gastric cancer[J] . Cancer Med, 2017, 6(1):235-244. [19] Wu Y, Yun D, Zhao Y, et al. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer[J] . Oncotarget, 2017, 8(1):1262-1277. [20] Singh P, Ravanan P, Talwar P. Death associated protein kinase 1(DAPK1):a regulator of apoptosis and autophagy[J] . Front Mol Neurosci, 2016, 9:46. [21] Piriyapongsa J, Jordan IK, Conley AB, et al. Transcription factor binding sites are highly enriched within microRNA precursor sequences[J] . Biology Direct, 2011, 6:61. [22] Strietz J, Stepputtis SS, Precac BT, et al. ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer[J] . Oncotarget, 2016, 7(50):83278-83293. [23] Guo H, Xu Y, Fu Q. Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation[J] . Tumor Biology, 2015, 36(11):8511-8517. |